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Background: The majority of obese subjects are treated by primary care physicians (PCPs) who often feel
uncomfortable with the management of obesity. In a previous study, we successfully developed, implemented
and evaluated an obesity management system based on training and coaching of health professionals of family
medicine groups (FMGs) by a team of experts in obesity management. Using a pre/post design, this study
suggested a positive impact on health professionals’ perceptions and reported obesity care. The current research
project is aimed at evaluating the impact on obesity screening and care of this integrated obesity management
system. We hypothesize that our program combining preceptorships with a virtual community and on-site coaching
will improve: (1) management and weight loss of obese/overweight subjects treated by PCPs for hypertension, type
2 diabetes or impaired glucose tolerance; and (2) screening and initial management of obesity among a regular
follow-up group of patients of PCPs who practice in FMGs.
Methods/Design: Ten FMGs will be approached for a practice monitoring project and will be randomised to
receive the intervention developed in our previous project or will only be provided clinical practice guidelines.
In the participating FMGs, we will enrol 22 patients per FMG with weight related targeted disease and 24 patients
with regular follow-up. These patients will be evaluated for the care they received regarding screening and/or
management of obesity using medical chart reviews, and will fill out a questionnaire on their lifestyle and satisfaction.
They will also be examined for anthropometric measures, vital signs, blood markers for chronic diseases and physical
fitness. The same patients will be assessed again after 18 months. The impact of the program on health professionals
will be evaluated at baseline, and at 1 year. Qualitative data will also be collected from both professional and patient
participants. Direct and indirect costs and QALYs will be evaluated as indicators of cost-effectiveness.
Discussion: In the context of the dramatic increase in obesity prevalence and the low perception of PCPs’ self-efficacy,
providing efficient strategies to PCPs and interdisciplinary health care teams for management of obesity is crucial.
Trial registration: Clinicaltrials.gov Identifier: NCT00991640
Keywords: Primary care, Obesity, Lifestyle, Medical education, Continuum of careBackground
Obesity and management recommendations
Obesity is a major public health problem that was identi-
fied as an epidemic by the World Health Organization
(WHO) and is associated with multiple co-morbidities,
including type 2 diabetes (DM2), hypertension (HTN),
cardiovascular disease and cancers [1]. As of 2004, nearly* Correspondence: marie-france.langlois@usherbrooke.ca
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article, unless otherwise stated.60% of the Canadian population was reported as being
overweight or obese [2]. Over the last 18 years, the pro-
portion of the population considered to be obese has
increased by 53% in Canada, but fortunately, the preva-
lence now seems to have stabilized [2]. Overweight and
obesity affect all age groups, including approximately 1
out of 4 children and adolescents [2-4]. The direct cost of
obesity in Canada was recently estimated at 4.3 billion
dollars, in addition to 5.3 billion dollars related to seden-
tary lifestyles: these costs represent 4.8% of the global
Canadian health care system’s budget [5]. Nonetheless,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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markedly ameliorate DM2, blood pressure, lipid profile
and may decrease mortality [6-10].
In response to the alarming evolution of obesity in
Canada, the 2005 federal budget provided $300 million
over 5 years for a strategy focusing on healthy living and
prevention of chronic disease [11]. Moreover, from 2006
to 2012, the Government of Quebec undertook an im-
portant action plan to promote healthy lifestyles and to
prevent obesity related health problems. This program,
called “Investing in the future”, consists of interventions
aiming to: i) promote healthy nutrition, physically active
lifestyles and favorable social norms; ii) improve services
for overweight and obese individuals and; iii) encourage
research and knowledge translation. Their goals for 2012
are to reduce by 2% the prevalence of obesity and that of
overweight by 5%, among children and adults in Quebec
[12]. Our research proposal is thus completely in line
with these objectives and is developed in partnership
with our local health agency (ASSSE) and the Quebec
Ministry of Health (MSSS).
The “2006 Canadian Clinical Practice Guidelines on
the Management and Prevention of Obesity in Adults
and Children” (CCPGO) emphasize the importance of a
multidisciplinary health care team for weight manage-
ment and include evidence-based key recommendations
for the clinical management of obesity [4]. They suggest
a stepwise obesity and overweight management algorithm
which can be applied in primary care. Furthermore,
CCPGO put a special emphasis on the need for research
to develop and evaluate the organization of care for over-
weight and obese individuals and also on the need for
continuing education to focus on activities that provide
physicians and health professionals with the skills to
counsel people confidently. Our project is in line with
these guidelines and will also help in appropriate know-
ledge transfer of the CCPGO that is needed in order to
implement them in clinical practice.
Inter-professional collaboration and organization of
primary health care services
The implementation of family medicine groups (FMG)
in 2001 resulted in major organizational changes in
primary health care services in Quebec [13]. A FMG is
a group of family physicians who practice together in
collaboration with nurses and other health care profes-
sionals and are responsible for ensuring primary care
services 24/7 in a given territory. Improved accessibility
and continuity, interdisciplinarity and patient registration
are central principles of that reorganization. FMGs pro-
vide further opportunities to improve care for specific
conditions that warrant lifestyle modifications and call for
interventions that are based on inter-professional collab-
oration. This construct refers to individuals from distinctdisciplinary backgrounds, who work together to achieve a
common goal. In today’s delivery of health care services
where different professionals, especially physicians and
nurses, are bound to work together, a collaborative
approach may enhance quality of care and quality of life
for patients [14-16]. A collaborative approach also involves
patients and is reputed to promote their empowerment
giving them the support to i) mobilize their resources; and
ii) focus on their strengths allowing them to take charge
of their situation [16]. Thus, obesity represents a special
challenge that is increasingly addressed in some FMGs
and benefits from a collaborative approach as outlined in
the CCPGO [4,17].
Models of care for chronic disease
The chronic care model (CCM) was developed and vali-
dated by the MacColl Institute for Healthcare Innovation
and constitutes an organizational approach to caring for
people with chronic disease [18,19]. It describes practical,
supportive, evidence-based interactions between an infor-
med, activated patient and a prepared, proactive practice
team. The CCM identifies essential elements of a health
care system that encourage high-quality chronic disease
care including: the community; the health system; self-
management support; delivery system design; decision
support, and clinical information systems [18,20,21]. A
meta-analysis of 112 studies has shown that interventions
that contained one or more CCM elements improved clin-
ical outcomes and processes of care [22]. This framework
was used to develop our intervention.
It was complemented by a theoretical model for chan-
ging lifestyle behaviour developed by Maryon-Davis: the
Three ‘Es’ Model which includes Encouragement, Em-
powerment and Environment [23]. Encouragement refers
to support patient efforts to change their lifestyle mainly
in regard to diet and physical activity. This support can
be provided by allied health professionals, primary care
physicians (PCPs) or even through media and social
programs. Encouragement needs to be supported by em-
powerment, which is based on patient education and the
acquisition of effective skills to concretely modify behav-
iour. The third E, which may be the most important,
refers to the alliance of the cultural, social, physical and
economic environments required to assist in lifestyle
factor improvements such as nutrition and exercise.
Interestingly, this model can also be applied to PCPs:
increasing their knowledge, giving them accurate ways
to manage obesity and offering them the support of an
expert team as ways of increasing their self-confidence
and self-efficacy which should ultimately have positive
effects on their clinical practice and patients.
Thanks to inter-professional collaboration, expert-
supported FMGs are an ideal setting for obesity manage-
ment according to CCM and the Three “Es” Models as
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to patients within the health care system.
Obesity management in primary care
Considering the growing prevalence of obesity, the
majority of patients should be managed by primary care
givers. Unfortunately, PCPs and health professionals
often feel that they are unable to help their patients lose
weight and their self-efficacy in obesity treatment is poor
[24,25]. As a result, obesity tends to be neglected when
compared to other chronic conditions like hypertension
and diabetes. When auditing medical records from PCPs,
obesity is definitely underreported and recommendations
for weight control interventions are reported even less
[26,27]. It stands to reason that if obesity is not mentioned
in a patient’s record, it is unlikely that any intervention is
ongoing. This only highlights the need for major changes
with respect to medical practice regarding this important
health problem.
Since 2004, a United Kingdom team set up a pro-
gramme for weight management in primary care: the
“Counterweight Programme” [26]. They recruited a total
of 80 practices from seven different regions of the United
Kingdom, of which 18 were randomly assigned to act as
controls. In each practice of the intervention group, 50
obese and 50 age- and sex-matched normal weight pa-
tients were selected for a total of 1906 patients. At base-
line, less than 58-71% of patients had a BMI measurement
and only 13-16% of obesity diagnoses were recorded, sup-
porting suboptimal screening and under-reporting of this
condition in primary care. Primary care nurses (PCNs)
were identified as the most suitable individuals to deliver
the weight management intervention and received 12 h of
training followed by 6 months of mentoring. The PCNs
were encouraged to see patients previously referred by
PCPs for six individual appointments or for six group
sessions during a period of three months followed by
quarterly meetings. Evaluation of the impact of the inter-
ventions on patients was then made at 12 and 24 months.
Forty-nine percent of patients were considered as com-
pleters of the programme (based on follow-up compli-
ance). At 12 months, 40% of completers and 33% of all
patients followed-up (including non-completers) achieved
a ≥5% weight loss that was mostly maintained at two
years. This suggests that empowerment and education of
patients in a primary care setting can have a success-
ful impact on modification of their health behaviour
and weight.
Electronic tools in obesity management
Coupling a preceptorship with a virtual learning commu-
nity (as further described below) and specific tools for the
practice setting can be key ingredients to effect change in
practice. Internet based communication, accessed at one’sown time in the clinic or at home, or used for same-time
meetings, is transforming the continuing information
environment. eLearning is becoming increasingly popular
and has been proven to be at least as effective as classical
continuing medical education (CME) to improve know-
ledge, and may initiate changes in medical practice [28].
This learning web-based architecture supports differ-
ent dimensions and different theoretical considerations,
including cognitive, educational, organizational, sociolo-
gical, technical and other disciplines, all of which underlie
the creation of this architecture. The various actors, spe-
cialists and community care givers, physicians, nurses,
nutritionists and other team members, patients and their
families make up a learning community. The term “virtual
learning community” has recently gained common use
where supported by web based communications [29-31].
It defines the cooperative process and is not restricted to
structured courses. They follow integrative global objec-
tives and require facilitation and technical expertise if they
are to be sustained. Potential advantages of an eLearning
community include a more fluid communication across
the different actors enabling consensus or resolving of
complex situations as well as flexibility with respect to
different working environments and ethos [29-31].
Contributions from our group and preliminary data
Our group has implemented an interdisciplinary approach
to obesity care management since 2001. Our interdis-
ciplinary team includes nurse-clinicians, dietitians, a psy-
chologist, kinesiologists and several endocrinologists. It
offers, under the coordination of the nurse-clinician, a
variety of behavioural and motivational approaches to life-
style modification through a series of group seminars in
addition to individual consultations with health profes-
sionals every 6 weeks, or as needed. To our knowledge,
such a system without out of pocket costs to the patient is
almost unique in Canada. Prospective studies of obese
patients with metabolic co-morbidities managed by our
multidisciplinary team reveal that 45-55% lose 5% or more
of their initial body weight after 12 months in our pro-
gram [32,33]. This is accompanied by important metabolic
benefits [33,34]. The effectiveness of our intervention is
thus comparable to other effective but more intensive and
costly interventions [8,9,35], making it more feasible in
the context of the Canadian health care system.
We have developed a model, based on the chronic care
model, emphasizing the importance of primary care
supported by regional experts, to improve obesity man-
agement throughout the continuum of care (Figure 1).
In 2005, we obtained a first CIHR-PHSI grant to de-
velop, implement and evaluate an obesity management
system based on preceptorships in combination with a
virtual community favouring continuous support of FMGs
by our expert team [36]. This program aimed to enhance
Figure 1 Model of integrated obesity management.
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obesity management, foster the implementation of nurse-
coordinated team management for obesity in primary care
settings, and improve access to quality support resources
for PCPs and their teams, as well as their patients. Thirty-
eight participants (13 nurses, 25 MDs) from 8 FMGs were
enrolled in the project [37] and evaluated at baseline and
1 year later.
After an extensive needs assessment, a 2-day precep-
torship was developed combining interactive sessions
with experts, case discussions and observation of real
patient encounters [38]. The preceptorship was validated
and remodeled with the participation of one of the FMGs
before being offered to all participants. A web-based
portal with professional and patient tools in association
with monthly interactive on-line educational activities for
health professionals was implemented in tandem with pre-
ceptorships as the key ingredients used to effect change in
practice [39].
Health professionals’ confidence level, attitude toward
obese individuals and perception of self-efficacy to advise
on exercise and diet improved after the preceptorships
and these improvements were maintained 1 month and
1 year after as compared to baseline [25]. Clinical practice
also seemed to improve with an increase in self-eported
waist circumference measurement, evaluation of patient
readiness to change and suggested use of a pedometer and
food diary [25].
Our next step is now to evaluate the impact on health
professionals’ clinical practice and patient-related outcomesof such an integrated model of obesity management and to
move from a pre-post design to the stronger design of a
randomized-controlled trial (Phase-2).
Hypothesis
We hypothesize that our program combining precep-
torships with a virtual community (intervention) will im-
prove: (1) screening and initial management of obesity
among unselected patients of PCPs who practice in FMGs;
and (2) management and weight loss of obese and over-
weight subjects who are treated by PCPs for HTN, DM2
or impaired glucose tolerance (IGT). We further hypo-
thesize that: (3) these benefits will be achieved through
improvement of primary care providers’ confidence
and competence in managing obese patients, as well as
changes in their clinical practice of obesity care; (4)
patients will express better satisfaction regarding their
management; and (5) our research program will result in
generalizable and transferable new knowledge useful for
decision-makers of the healthcare system.
Aims of the study
Primary aims
1. Among patients who are regularly followed by a
PCP for weight-related diseases targeted for
lifestyle management (HTN, DM2 or IGT) and
with a BMI ≥ 25 (targeted diseases group), we aim at
improving, after 18 months of participation in our
program (vs. control):
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initial weight management intervention
planned;
1b) the proportion of subjects who lose at least
5% of their initial weight;
1c) weight, waist circumference, lean body mass,
blood pressure, physical fitness level, physical
activity level and healthy eating habits;
1d) biochemical markers of metabolic control and
cardiac risk (HbA1c, ApoA and ApoB).
2. Among patients who are regularly followed-up by a
PCP for other health conditions (regular follow-up
group), we aim at improving after 18 months of
participation in our program (vs. control):
2a) the proportion of patients who have measured
weight, BMI and waist circumference;
2b) the proportion of overweight or obese subjects
who have an initial intervention planned;
2c) weight, waist circumference, lean body mass,
blood pressure, physical fitness level, physical
activity level, healthy eating habits and markers
of metabolic control in overweight or obese
subjects.
Secondary aims
3. Among health professionals who receive the
intervention (vs. those who did not), we aim at:3a) ameliorating their attitudes and perceptions
towards patients and treatment effectiveness;
3b) improving their perception of self-efficacy in
managing obesity;
3c) increasing their knowledge and expertise on
obesity management; and
3d) changing their practice.
4. Among patients who are followed by PCPs
(both targeted disease and regular follow-up groups)
who receive the intervention (vs. control),
we aim at:
4a) evaluating their attitudes and perceptions
regarding obesity/overweight and lifestyle; and
4b) improving their satisfaction regarding their
management.
5. Evaluate costs and indicators of cost-effectiveness
of the intervention.
6. Transfer knowledge to intervening parties and
decision-makers of the health system using
embedded knowledge transfer to patients, healthprofessionals and decision-makers in addition to
traditional end-of-grant strategies.Methods/Design
Research design
A schematic representation of research design is presented
in Figure 2.Study participants
The Integrated University Health Network, known as
the RUIS (Réseaux universitaires intégrés de santé), of
Université de Sherbrooke caters to a population of over 1
million people, encompassing a vast territory including
Sherbrooke and Montérégie areas. A pool of at least 35
FMGs in this coverage area did not participate in our
Phase-1 project. We will enroll a total of 10 of these
FMGs in Phase-2, from which 4-10 members (including
at least 2 PCPs and 1 nurse) will participate in our study.
When we will initially contact FMGs, we will propose to
them a study assessing lifestyle management in primary
care and its evolution over time. When we will be in
contact with 2 interested FMGs, we will randomize them
to the intervention or control groups. The first FMG will
then be offered to participate in our obesity management
system with preceptorships and virtual learning commu-
nity. The control FMG will be offered practice monitor-
ing without being aware of the intervention. Participants
of each group will sign different consent forms.
As much as possible, we plan to evaluate participants
from FMGs pairs of intervention and control groups
concomitantly in order to avoid bias related to time of
evaluation (due to seasonal effects on weight, campaigns
of health promotion, high-impact scientific publications,
etc.). Within each FMG, adult patients who present for
follow-up will be offered by FMG clerical personnel to
have their chart accessed by our team and to be contac-
ted if eligible for the project. If they consent, their chart
will be screened to verify if they had, during the past
2 years, at least 4 documented visits for the targeted dis-
ease group and at least 2 visits for the regular follow-up
group, and if continued follow-up is planned or highly
probable in the next 18 months. We aim to include in
our study 22 patients per FMG in the targeted disease
group, and 24 patients per FMG in the regular follow-up
group (total of 460 patients). Patient numbers will be
prospectively accrued within each patient category during
the recruitment period and before preceptorship delivery
for the intervention group, until targeted numbers are
achieved. In order to minimize important potential biases,
patients will be kept blinded regarding their FMG group
and the study objectives related to the evaluation of this
intervention.
Targeted diseases and 
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Figure 2 Summary of design of the proposed research project.
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The educative intervention is based on the format devel-
oped during our Phase-1 project, i.e. a two-day precep-
torship combining theoretical and practical CME, and
includes both plenary and nurse- or PCP-specific sessions.
At the beginning of our Phase 2 project, we thoroughly
reviewed the content of the preceptorship according to
expert opinions relevant literature and comments/sug-
gestions from Phase-1 participants. All important topics
concerning CCPGO recommendations are covered, such
as initial evaluation of patients (including readiness for
change), nutritional approach, physical activity, behaviour
modification and support to patients, pharmacotherapy,
indications for bariatric surgery, obesity in children and
adolescents etc. Training is divided into two days that are
provided approximately 1 month apart in order for par-
ticipants to put new knowledge into practice and better
identify areas to emphasize during the 2nd day. More
than half of the time is devoted to the observation of
real patient encounters and case discussions. Sessions
are given by members of our research team who are
also involved in the Centre Hospitalier Universitaire
de Sherbrooke (CHUS) obesity clinic: endocrinologists,
pediatric endocrinologist, dietician, kinesiologist and
psychologist, according to their field of expertise. The
general objective of the preceptorship is to increase
self-efficacy and optimize interventions of healthprofessionals regarding obese and overweight patients in
complementarity with specialized interdisciplinary resour-
ces of the CHUS obesity clinic.
The intervention group also has access to the virtual
community previously described, including the web site
posting information for health professional and patient
tools, monthly virtual meetings where advances in obesity
management and difficult cases are discussed, and a dis-
cussion forum for participants and obesity experts.
Following expressed needs of participants at the end
of Phase-1, we are also providing on-site coaching
sessions for FMG participants every three months.
They consist of 1 hour discussions with the dietician or
kinesiologist of our team who visits the FMG to solve
problems with web-site use, solve difficult cases, discuss
use of program tools and explore practice changes. The
objective is to help participants integrate the virtual
community in their practice and answer their clinical
questions.
The FMGs allocated to the control group are only
provided with a copy of the current Canadian guidelines
for the treatment of obesity, diabetes, dyslipidemia and
HTN [4,40-42].
Ethical considerations
The research project was reviewed and approved by the
appropriate institutional Research Ethics Review Boards
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Statement. Research participants (both patients and health
professionals) were duly informed and consent was ob-
tained in writing prior to participation. However, as men-
tioned above, subjects were not informed regarding the
intervention. They were told that the objective of the
study was to evaluate lifestyle management in primary
care settings and its evolution over time. In order to
minimize deceptive ethical issues, all participants will be
fully informed of all the objectives and interventions of
the study after their final assessment, with appropriate
debriefing. Initial contact of potential candidate patients
was performed by FMG clerical personnel who gave them
a pamphlet with information on the study and obtained
their signed consent to have their chart reviewed by the
research team and to be contacted if needed. Ethical con-
siderations raised by the research are mainly confidential-
ity issues. All data will be coded, archived for at least
5 years and then destroyed.
Variables and research tools
Evaluation of patients
All evaluations will take place at baseline and after
18 months in order to allow sufficient time following
the intervention to monitor changes in practice. Al-
though very long term weight maintenance cannot
be assessed during that period, we could eventually
continue following patients on a longer term as part
of future projects.
Anthropometric measures and vital signs
Weight will be measured in patient participants by a
standard calibrated scale in kilograms to the nearest
decimal (0.1 kg) wearing indoor clothing, with empty
pockets and without shoes. Height will be measured
with a stadiometer in meters to the nearest millimeter
(0.001 m), without shoes. Waist circumference will be
measured twice with a measuring tape at the top of the
upper iliac crest, at the end of a normal expiration, as
recommended; we will record the average of 2 measures
with less than 1 cm variation [4,43]. Lean body mass, fat
mass (in kg) and percent body fat will be measured by
standing electric bioimpedance using a Tanita weight
scale (model TBF-300A). Standing electric bioimpedance
was shown to be reliable compared to underwater weigh-
ing and to conventional supine tetrapolar bioimpe-
dance [44-46]. Blood pressure and pulse rate will be
measured after five minutes of rest, in the sitting pos-
ition. The average of two measurements will be used
for analysis.
Medical history and lifestyle interventions
At the end of the study for each study site, thorough
medical chart review will be performed using a standardizedevaluation grid, also verifying medical and surgical history
and medications for the 18 months before and after baseline
evaluation of patients. Evaluations and interventions that are
proposed to patients will be compared to that proposed in
the CCPGO algorithm, and evolution of patients’ weight
during the observation period will be recorded.
Metabolic markers
We chose metabolic markers not influenced by a fasting
state in order to increase feasibility of blood sampling
during patient evaluations. We will use HbA1c which
correlates with glycemic control in patients with DM2
and is also a marker of dysglycemia which can be used
to diagnose pre-diabetic states and DM [47]. Furthermore,
HbA1c was identified as a good marker of cardio-vascular
events even in non-diabetic individuals [48]. Lipopro-
teins ApoB (marker of atherogenic LDL particules) and
ApoA1 (marker of protective HDL particules) will be
used [42,49,50]. Apo B is thought to be a better marker
of cardiovascular risk than LDL and a better predictor of
treatment benefits [40,49,51]. Furthermore, ApoA1 and
ApoB/ApoA1 ratio are expected to improve with weight
loss and lifestyle modification and can be used as bio-
markers of improved cardio-vascular risk [49,50,52,53].
These will be measured in the CHUS clinical biochemistry
laboratory using standard methods.
Lifestyle
Physical activity level and eating habits will be mea-
sured using a questionnaire adapted from the one
used by Statistics Canada for the latest Canadian Health
Survey [54]. It inquires about the frequency and duration
of active travelling, leisure time, and sedentary activities.
We chose this questionnaire since it is easy and quick to
complete and allows comparison of the characteristics of
our patients to those of the general Canadian population.
Fitness level
Since objective measurements of exercise capacity in
patients are usually better than self-reports, we will use
the six-minute walk test (6MWT), a simple index that
estimates functional capacity in obese subjects and is
also a predictor of morbidity and mortality [55-57]. The
6MWT is a simple test that we will be performed in
FMGs where the environment permits according to the
protocol recommended by the American Thoracic Society,
and measures the distance that a patient can quickly walk
in a period of 6 minutes [58]. It has been shown that
weight loss increases functional capacity, as measured by
the 6MWT, early in the weight loss process, making this
test a very accurate tool to evaluate the impact of the
intervention on obese/overweight patients’ functional cap-
acity [59-61].
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In the course of previous prospective studies, we have
designed a 22-question weight loss readiness tool (WLRT)
based on Prochaska and DiClemente’s Stages of Change
Model, which is currently being validated [4,62]. It eva-
luates the motivational readiness of patients regarding
weight management, nutrition and physical activity, and
could predict response to an intervention. Our WLRT
takes 5-10 minutes to fill out, making it a clinically applic-
able tool. It has been useful to identify subjects with
greater chances of success for lifestyle modification in pre-
vious studies of our group [63,64]. Its predictive value will
be assessed in this study, but it will also serve to explore
the mechanisms of potential benefits of our intervention
and for stratified analyses.
Conformity to CCM
We will be using the Patient Assessment of Chronic Ill-
ness Care questionnaire (PACIC), developed and validated
by the McColl Institute to evaluate perceived concordance
of received care with the CCM [18,20,21]. We used the
World Health Organization process of translation and
adaptation of instruments to translate the questionnaire
into French [65].
Perceptions and satisfaction of patients
Patient perceptions of their personal experience re-
garding weight management and their satisfaction re-
garding management by their health professionals will
be evaluated with questionnaires that we designed
based on previous studies. A qualitative in-depth ana-
lysis of patients’ perceptions will also enhance our
understanding of their personal experience with the
care received for lifestyle optimization in FMGs. Eight
to ten patient volunteers will be recruited in each FMG to
participate in a taped-recorded semi-structured qualitative
interview to assess their perceptions of impact of the
program (continuity of care, perceptions of changes,
contribution to change, quality of life, perspectives of
future changes, explanation of level of satisfaction with
the program). An interview guide with open-ended ques-
tions derived/adapted from the principal variables of the
study, the Diabetic Empowerment Scale (DES) [16], and
the Weight-related Quality of Life (WQOL-lite) question-
naire [66] will be used as in previous studies from mem-
bers of our group [33,67].
Evaluation of health professionals (PCPs and nurses)
All evaluations will take place at baseline, T1
(1 month after the preceptorship for the intervention
group and 1 month after baseline for the control
group) and 12 months after T1 in order to compare
the data collected during our Phase 1 study and to
compare intervention and control groups. The samequestionnaires that we developed and validated will
be used to evaluate Aim 3 of this proposal. We have
slightly modified some tools based on the results of
our Phase 1 project. Results will be correlated to pa-
tients’ outcome.Attitudes, perceptions and self-efficacy toward obesity
management
Self-efficacy is defined as the set of beliefs about one’s
capabilities to perform at a designated level [68]. For
health professionals to engage in weight management
with their patients, they must not only accept this as
part of their role but also feel that they are competent to
accomplish the task. Indeed, 3 stages were identified in
physician learning [69]: i) deciding whether to take on a
learning task to address a problem; ii) learning the skill
and knowledge anticipated to resolve the problem and
iii) gaining experience in using what has been learned.
Negative attitudes toward obese individuals and percep-
tions to the effect that available treatments are inef-
fective (as found at baseline in our Phase-1 study), can
prevent the engagement of health professionals in weight
management [24,25,70]. Thus, by providing participants
with the necessary knowledge, skills and continued sup-
port to undertake weight management with their patients,
we believe that we will be able to initiate what Tiberius
and Tipping considered a “healthy spiral”: beginning with
an acceptance of inherent challenges (related to weight
management) and moving to success at those tasks (help-
ing patients) and finally to the development (through
experience) of a more positive sense of self-efficacy [71].
Changes in attitudes and perceptions could be correlated
to changes in practice and patient outcomes. This will be
evaluated using questionnaires that we developed in our
previous project based on the literature.Knowledge and expertise on obesity management
To assess the impact of our intervention on medical
knowledge regarding obesity, physicians and nurses will
be asked to respond to a short-answer and multiple-
choice questionnaire of 25 questions. The questionnaire
will address topics related to obesity management such
as physical activity and nutritional recommendations a
and non-obesity related topics such as management of
hypertension or tobacco cessation.Conformity with CCM
We will be using the Assessment of Chronic Illness Care
questionnaire (ACIC version 3.5), developed and validated
by the McColl Institute to evaluate the organization of
care in the FMG corresponding to each element of the
CCM [18,20,21,72].
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A services evaluation grid will be completed with the
administrator of the FMG in order to assess practice
organization. Also, individual practice of participants will
be assessed using clinical vignettes describing a patient
presenting for a routine exam or for weight management.
This tool was used in our previous study to demonstrate
changes in reported management of obesity. A qualitative
in-depth analysis of participants perceptions of the pro-
gram will be performed using semi-structured interviews
in each FMG [36]. This will increase our understand-
ing of their experience, inter-professional collabor-
ation, satisfaction with the program, change process
and further identify and detail strengths and areas for
potential improvement.
Evaluation of cost-effectiveness
We will thoroughly evaluate direct and indirect costs of
implementation and delivery of our intervention, which
are multiple: costs for the instigators of the program
(using a log book for all team members involved in
delivery of the intervention, etc.); costs for FMG profes-
sionals; costs for visits to other health care facilities
where patients seek care for their specific problem of
obesity/overweight; costs for patients; and costs to soci-
ety modelized in a Markov model using data from the
literature and the study [73,74]. Once data on all of
those costs will be collected and compared between the
two groups, a sensitivity analysis will be conducted with
different scenarios over several years and with different
discount rates to reflect the uncertainty of some vari-
ables [75].
Quality Adjusted Life Years (QALYs)
It is now recognized that to better treat the patient, and
not only the disease, doctors should take into account
the patient’s quality of life related to health. We will thus
be using the most used questionnaire, the SF-36, derived
from the “Medical Outcome Study” completed by patient-
participants [76]. To address the most important limita-
tions of the SF-36 and build an instrument that allows us
to conduct a cost-effectiveness analysis, we will apply the
transformation of Brazier et al. [77] to obtain QALYs
based on stated preferences of individuals through the
method of “Standard Gamble” (lottery). This transform-
ation allows to take into account: 1) the existence of
differences in individuals’ preferences between different
dimensions of health, and 2) the possibility that the inter-
val between different possible answers to each question in
the SF-36 is not equal. The transformation model chosen
will be model number 10 [78]. A complementary measure
of QALYs will also be used to ensure consistency and
continuity of results. This additional measure is to apply a
time trade-off issue in the preferences of individuals [79].This issue will be formulated as follows: “We make the
assumption that for reasons that cannot be changed, you
only have 10 years to live. Of these 10 remaining years to
live, how many years of life would you be willing to give
up to live the remaining years with a weight 20% less than
what your weight is now?”
Sample size, data analysis and interpretation
According to AIM 1, our primary variable of interest is
the proportion of obese or overweight subjects with
HTN, DM2 or IGT who will lose least 5% of their initial
weight after eighteen months. Assuming that 30% drop-
out or provide incomplete data, our study needs to
recruit 220 obese or overweight subjects with HTN,
DM2 or IGT in order to achieve 80% power (using chi-
square) to detect a doubling in the proportion of those
who will lose at least 5% of their initial weight, based on
a proportion of 21% in the control group (which is the
average proportion observed in the control groups of
two of our previous studies) [32,33,67] and 42% in the
intervention group (which represent half of the average
benefits found in these two studies compared to control
groups) (AIM 1). Similarly, 240 unselected patients pro-
vided 80% power (using Fisher’s-exact test because of
small minimum expected cell size) to detect an improve-
ment of the proportion of these patients who have a
reported measure of BMI from 80% in the control group
(based on reported practice in our previous participants)
to 95% in the intervention group (which is close
to the 100% recommended by the CCPGO) (AIM 2).
For AIM 2, our primary variable of interest is the
proportion of unselected patients who have a reported
measure of BMI, which defines obesity according to
WHO and is therefore essential for the screening of
obesity.
The impact of our program on patient’s care will be
assessed by the comparison of patients’ outcome vari-
ables between those recruited from FMGs allocated to
intervention and those recruited from FMGs allocated
to no intervention. Similarly, the impact of our program
on PCPs will be determined by the comparison of vari-
ables related to PCPs between those who received the
intervention and those who did not. Univariate analyses
will use two-tailed unpaired t tests to compare continu-
ous variables and chi-square or Fisher’s-exact tests to
compare categorical variables. Continuous variables that
are not normally distributed will be log-transformed
in order to ascertain normal distribution, whenever
possible, or will be compared using two-tailed Wilcoxon
tests. Multivariate analyses will also be used in order to
adjust for baseline differences between groups, potential
confounders and cluster effects of individual FMGs.
Should differences between patients’ or PCPs’ groups be
evidenced, Pearson correlation analyses will be performed
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mechanistic variable. For example, benefits in patients’
outcome variables will be correlated with changes in vari-
ables assessing attitude, perceptions, knowledge and/or
better clinical practice for their primary care providers.
An α level of 5% will be used for all analyses.
Knowledge translation plan (Aim 5)
It is worth mentioning that our research program is
optimal to allow knowledge translation (KT) and ap-
plication throughout the entire research process. The
preceptorship experience in itself is a knowledge transla-
tion activity for health professionals. Our group is also
actively involved in developing a National Preceptorship
program with the Canadian Obesity Network (CON) and
this could evolve in the development of a national virtual
community and improvements in CON CME activities.
Evidence-based information on patient outcomes gener-
ated by our study will have a great impact on knowledge
transfer: if beneficial, it would accelerate the imple-
mentation of such programs as practice models; and
if benefits are less than expected, it will orientate to
program modification.
However, research by itself does little to induce change
(except for participants) and thus, results have to be dif-
fused to interested audiences. We have access to special-
ized communication resources from the CHUS Research
Center and CON to develop an optimal strategy for
dissemination of results and potential applications.
Our research is relevant to PCPs, nurse coordinators,
specialists in various disciplines and associated health
professionals, CME departments, public health director-
ates, health-system decision-makers. We will reach out
to these parties through linkage and exchange activities,
including presentation of study results at scientific meet-
ings and publication in scientific journals, but also by
direct reports to decision-makers and health policy
stakeholders. A clear summary of research results, includ-
ing key messages targeted for each selected audience and
synthesized results (divided by themes) will be available
(printed and on our web site). Local and national media
will be invited to press conferences and we will schedule
private meetings with important decision-makers to whom
our findings are relevant.
Discussion
Impact
The outcome measures of our proposal are relevant and
useful to a number of health systems’ managers and
policy makers. The ASSSE, as well as stakeholders from
the Ministry of Health of Quebec, Canadian Obesity
Network and FMGs, are decision makers active in this
research project and results will impact on the planning,
allocation and management decision of policy makers asthey apply to service organizations. Early involvement of
policy makers as co-investigators and active participants
in our research project and their interactions with our
team since 2005 will considerably increase the likelihood
that they feel ownership of the findings. Their implica-
tion in our first partnership program was greatly appre-
ciated and their interest is growing: they regard as very
pertinent the assessment of direct impact on patients’
care as proposed in this project and positive results will
greatly impact on their willingness to implement such
interventions. Research results are anticipated to be ap-
plicable to other institutions and regions of Quebec and
Canada because most regions have access to specialists
who could support networking with a PCP team. Our
evaluation will also allow us to improve the program
and knowledge transfer will be greatly facilitated by our
partnership with CON.
Importance and generalizability
This project is very important as it generates new know-
ledge on cost-effective and applicable measures for the
management of obesity and should improve access
to care for obese and overweight patients by engaging
primary health care teams. We know that obesity is an
important public health problem that leads to adverse
medical complications and that it can be treated effect-
ively to reduce not only weight but also co-morbidities
and mortality. However, comprehensive obesity man-
agement is seldom undertaken in primary care due to
inadequate training, insufficient resources and poor
self-efficacy. Our preliminary data show that the obesity
management system developed by our team significantly
improves perceptions, attitudes and low perceived self-
efficacy of PCPs and PCNs and changes their reported
practice. This is extremely promising, but evaluation
of the impact of such a system on measured patient
outcomes through the current project is necessary before
changing a health care system’s organization. Gene-
ralizability of our findings is high since expert teams
in the management of obesity are present throughout
Canada (already networking through CON), and primary
care is developing teams of PCPs and nurses in many
Provinces. Also, this model could apply to the manage-
ment of other chronic diseases and be adapted to other
health care systems.
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